|
20:38 | In latest blow to Eli Lilly, Sanofi wins FDA OK for Humalog me-too | - | Endpoints News | |
20:19 | UPDATE 1-FDA OKs Sanofi's follow-on biologic of Lilly's diabetes drug Humalog | 2 | Reuters.com | |
19:55 | FDA approves Sanofi's rapid-acting insulin analog Admelog; shares up 1% | 2 | Seeking Alpha | |
19:31 | FDA clears Sanofi's follow-on diabetes biologic of Lilly's Humalog | - | Reuters.com | |
19:16 | Sanofi: FDA Approves Sanofi's Admelog (insulin lispro injection) | 6 | GlobeNewswire (Europe |
eigentlich müssten sich Erfolge einstellen.
Der Zahlenkranz sieht auch gut aus:
PE Ratio (TTM) 13.05
EPS (TTM) 5.63
Earnings Date Feb 7, 2018
2017 Dividend & Yield 3.02 (4.12%)
1y Target Est 85.16
http://www.ariva.de/news/...s-r-amp-d-strategy-and-innovative-6669854
die Bankster haben genügend runter gedrückt.
Neue Erfolge, Beschleunigung des Genehmigungsverfahrens:
Paris and Cambridge, Mass. - December 15, 2017 - Sanofi Genzyme, the specialty care global business unit of Sanofi, and Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today that the U.S. Food and Drug Administration (FDA) has lifted the hold on clinical studies with fitusiran, including the Phase 2 open-label extension (OLE) study and the ATLAS Phase 3 program.
|
Wertung | Antworten | Thema | Verfasser | letzter Verfasser | letzter Beitrag | |
6 | 287 | Sanofi-Aventis - interessante Patente +Ü.Phantasie | omega512 | Highländer49 | 25.04.24 12:33 | |
5 | Sanofi startet duch KZ 150 € | deadline | neymar | 24.04.21 23:23 | ||
11 | Aventis - Eine Übernahmeschlacht? | Strotz | ellogo2 | 31.03.15 10:51 | ||
3 | 1 | Vogelgrippe Welcher Impfstoff macht das Rennen? | moya | HausmeisterKrause | 19.04.06 07:37 | |
1 | Sanofi Call | fridolin | fridolin | 17.01.02 22:16 |